Cargando…

CD163 as a Potential Biomarker in Colorectal Cancer for Tumor Microenvironment and Cancer Prognosis: A Swedish Study from Tissue Microarrays to Big Data Analyses

SIMPLE SUMMARY: Through the analysis of tissue microarray (TMA) samples from colorectal cancer (CRC) patients and bioinformatical analyses of public databases and our clinical dataset, this study identifies the different expressions of CD163 in various tissues, the presence of the receptor in TME, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Shuwen, Zhao, Yuxin, Liu, Xingyi, Sun Zhang, Alexander, Zhang, Hong, Hu, Guang, Sun, Xiao-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776587/ https://www.ncbi.nlm.nih.gov/pubmed/36551651 http://dx.doi.org/10.3390/cancers14246166

Ejemplares similares

Impact of thymidine phosphorylase and CD163 expression on prognosis in stage II colorectal cancer
por: Kaidi, Donia, et al.
Publicado: (2022)

CD163 and CCR7 as markers for macrophage polarization in lung cancer microenvironment
por: KWIECIEŃ, IWONA, et al.
Publicado: (2020)

Prognostic significance of CD163+ tumor-associated macrophages in colorectal cancer
por: Xue, Tao, et al.
Publicado: (2021)

Characteristics and clinical significance of CD163+/CD206+M2 mono-macrophage in the bladder cancer microenvironment
por: KONG, Xiangjie, et al.
Publicado: (2021)

Elevated CD163(+)/CD68(+) Ratio at Tumor Invasive Front is Closely Associated with Aggressive Phenotype and Poor Prognosis in Colorectal Cancer
por: Yang, Chaogang, et al.
Publicado: (2019)

CD163+ Tumor-Associated Macrophages Correlated with Poor Prognosis and Cancer Stem Cells in Oral Squamous Cell Carcinoma
por: He, Ke-Fei, et al.
Publicado: (2014)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

Correlation of APE1 with VEGFA and CD163(+) macrophage infiltration in bladder cancer and their prognostic significance
por: Wang, Lin-Ang, et al.
Publicado: (2020)

CD47 expression and CD163(+) macrophages correlated with prognosis of pancreatic neuroendocrine tumor
por: Imam, Rami, et al.
Publicado: (2021)

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
por: Bravaccini, Sara, et al.
Publicado: (2019)

The correlation between infiltration of FoxP3(+) Tregs, CD66b(+) TANs and CD163(+) TAMs in colorectal cancer
por: Ren, Yuehan, et al.
Publicado: (2022)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
por: Farag, Azza Gaber Antar, et al.
Publicado: (2020)

Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss
por: Xie, Peilin, et al.
Publicado: (2022)

The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
por: Xu, Guozeng, et al.
Publicado: (2021)

The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma
por: Kong, Ling-Qun, et al.
Publicado: (2013)

High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis
por: Li, Philippa, et al.
Publicado: (2021)

CD163 is a predictive biomarker for prognosis of classical Hodgkin's lymphoma in Saudi patients
por: Ahmed, Huda Al Sayed, et al.
Publicado: (2019)

Expressions of miR-302a, miR-105, and miR-888 Play Critical Roles in Pathogenesis, Radiotherapy, and Prognosis on Rectal Cancer Patients: A Study From Rectal Cancer Patients in a Swedish Rectal Cancer Trial of Preoperative Radiotherapy to Big Database Analyses
por: Meng, Wen-Jian, et al.
Publicado: (2020)

Prognostic significance of the infiltration of CD163(+) macrophages combined with CD66b(+) neutrophils in gastric cancer
por: Huang, Xiaopei, et al.
Publicado: (2018)

High Infiltration of Polarized CD163(+) Tumor-Associated Macrophages Correlates with Aberrant Expressions of CSCs Markers, and Predicts Prognosis in Patients with Recurrent Gastric Cancer
por: Zhang, Wei-jie, et al.
Publicado: (2017)

Is sCD163 a Clinical Significant Prognostic Value in Cancers? A Systematic Review and Meta-Analysis
por: Qian, Shushu, et al.
Publicado: (2020)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers
por: Pelekanou, Vasiliki, et al.
Publicado: (2018)

Clinical Significance of CD163+ and CD68+ Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer
por: Chen, Xiao-Jing, et al.
Publicado: (2017)

Soluble CD 163: A novel biomarker
por: Ahuja, Rajeev B.
Publicado: (2011)

miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer
por: Zhang, Hongzhi, et al.
Publicado: (2019)

Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery
por: Garvin, Stina, et al.
Publicado: (2018)

Prognostic significance of the infiltration of CD163(+) macrophages combined with CD66b(+) neutrophils in gastric cancer
Publicado: (2018)

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Clinical significance of sCD163 and its possible role in asthma
por: Zhi, Yue, et al.
Publicado: (2017)

Local production of soluble CD163 in the spondyloarthropathic joint
por: Baeten, D, et al.
Publicado: (2003)

Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases
por: Skytthe, Maria K., et al.
Publicado: (2020)

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Polyamine metabolism patterns characterized tumor microenvironment, prognosis, and response to immunotherapy in colorectal cancer
por: Zhang, Enkui, et al.
Publicado: (2023)

CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood
por: Krijgsman, Daniëlle, et al.
Publicado: (2020)

CD14(+) monocytes and CD163(+) macrophages correlate with the severity of liver fibrosis in patients with chronic hepatitis C
por: Zhao, Su-Xian, et al.
Publicado: (2020)

Circulating Soluble CD163: A Potential Predictor for the Functional Outcome of Acute Ischemic Stroke
por: Sun, Houchao, et al.
Publicado: (2021)

Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment
por: Mori, Kazumasa, et al.
Publicado: (2015)

Effect of compounds on the purification and antibody preparation of the extracellular domain fragment of the receptor CD163
por: Cao, Zong-Xi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_serttkh68n168uqghg6vmcv7d9